Antifungal Therapy in Birds: Old Drugs in a New Jacket.

Antifungal Therapy in Birds: Old Drugs in a New Jacket.

Author:

Antonissen G, Martel A.

Date: 7 June 2018

Abstract:

The use of antifungals in birds is characterized by interspecies and interindividual variability in the pharmacokinetics, affecting drug safety and efficacy. Oral antifungal drug absorption is a complex process affected by drug formulation characteristics, gastrointestinal anatomy, and physiology. New antifungal drug delivery systems can enhance drug stability, reduce off-target side effects, prolong residence time in the blood, and improve efficacy. Topical administration of antifungals through nebulization shows promising results. However, therapeutic output is highly influenced by drug formulation and type of nebulizer, indicating these factors should be taken into account when selecting this medication route.

KEYWORDS: Amphotericin B; Antifungal; Drug formulation; Itraconazole; Nanoparticles; Nebulization; Terbinafine; Voriconazole

Link to DOI

Download the full article (Disclaimer)

This manuscript library of ~16,000 articles (1729-2024) related to Aspergillus and aspergillosis is intended for individual study only, and is provided as contribution to global understanding of the topic. Please refer to the publisher’s guidance about any other usage.